Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.68% |
| 2 | Technology | 12.88% |
| 3 | Consumer Staples | 9.84% |
| 4 | Communication Services | 9.02% |
| 5 | Financials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Agree Realty
ADC
$9.36B
| $1.16M | ﹤0.01% |
18,800
-26,000
| -58% | -$1.85M |
|
|
INFI
2352
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.16M | ﹤0.01% |
1,385,414
+127,101
| +10% | +$147K |
|
|
PW
2353
Power REIT
PW
$2.93M
| $1.16M | ﹤0.01% |
11,120
+1,464
| +15% | +$148K |
|
2354
CB Financial Services
CBFV
$190M
| $1.16M | ﹤0.01% |
59,998
-3,643
| -6% | -$98.5K |
|
|
PROF
2355
Profound Medical
PROF
$242M
| $1.16M | ﹤0.01% |
120,180
+107,280
| +832% | +$1.39M |
|
|
SSKN
2356
DELISTED
Strata Skin Sciences
SSKN
| $1.16M | ﹤0.01% |
121,685
+5,719
| +5% | +$94.4K |
|
2357
Viasat
VSAT
$11.5B
| $1.16M | ﹤0.01% |
32,193
-89,400
| -74% | -$5.16M |
|
|
AGEN
2358
Agenus
AGEN
$322M
| $1.15M | ﹤0.01% |
23,933
+4,493
| +23% | +$282K |
|
|
ADMS
2359
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.15M | ﹤0.01% |
398,380
+105,600
| +36% | +$473K |
|
2360
Hope Bancorp
HOPE
$1.86B
| $1.15M | ﹤0.01% |
139,900
-448,164
| -76% | -$5.6M |
|
2361
PCB Bancorp
PCB
$404M
| $1.14M | ﹤0.01% |
116,832
-3,500
| -3% | -$48.3K |
|
|
SIOX
2362
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.14M | ﹤0.01% |
468,123
+147,700
| +46% | +$533K |
|
2363
Cue Biopharma
CUE
$138M
| $1.14M | ﹤0.01% |
2,680
+1,234
| +85% | +$598K |
|
2364
Blue Owl Capital
OBDC
$5.86B
| $1.14M | ﹤0.01% |
+98,600
| New | +$1.44M |
|
2365
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
| $1.14M | ﹤0.01% |
+6,900
| New | +$1.03M |
|
2366
Curis
CRIS
$4.08M
| $1.14M | ﹤0.01% |
4,031
+185
| +5% | +$98.2K |
|
2367
Vanguard Morningstar Total Stock Market ETF
VTI
$696B
| $1.13M | ﹤0.01% |
8,800
-1,500
| -15% | -$232K |
|
2368
Innospec
IOSP
$2.31B
| $1.13M | ﹤0.01% |
16,300
-700
| -4% | -$63.9K |
|
2369
Columbia Banking Systems
COLB
$9.27B
| $1.13M | ﹤0.01% |
+42,106
| New | +$1.48M |
|
2370
Vanguard Morningstar Growth ETF
VUG
$231B
| $1.13M | ﹤0.01% |
+43,140
| New | +$1.29M |
|
|
TUES
2371
DELISTED
Tuesday Morning Corp
TUES
| $1.13M | ﹤0.01% |
1,957,690
+147,739
| +8% | +$211K |
|
|
AIOS
2372
AIOS Tech
AIOS
$39.1M
| $1.12M | ﹤0.01% |
739
-406
| -35% | -$555K |
|
2373
Protalix BioTherapeutics
PLX
$185M
| $1.12M | ﹤0.01% |
477,434
+17,800
| +4% | +$58.9K |
|
|
APTX
2374
DELISTED
Aptinyx Inc. Common Stock
APTX
| $1.12M | ﹤0.01% |
518,929
+211,279
| +69% | +$691K |
|
2375
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $1.12M | ﹤0.01% |
11,200
-9,800
| -47% | -$985K |
|
Similar funds
Jim Simons's Q1 2020 Portfolio in Review
As of Q1 2020, Jim Simons held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jim Simons's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Jim Simons added most to Baidu in Q1 2020, an estimated $462M increase.
- Jim Simons's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Jim Simons fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Jim Simons's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Jim Simons opened 573 new positions and closed 645 in Q1 2020.
- Jim Simons's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.